Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
SARS-CoV-2, the causative agent of COVID-19, is rapidly evolving to be more transmissible and to evade acquired immunity. To date, most investigations of SARS-CoV-2 variants have focused on RBD mutations.
Guardado en:
Autores principales: | Cong Zeng, John P. Evans, Julia N. Faraone, Panke Qu, Yi-Min Zheng, Linda Saif, Eugene M. Oltz, Gerard Lozanski, Richard J. Gumina, Shan-Lu Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0c840ac1f2942deb9396a8f2361fbdc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
por: Cong Zeng, et al.
Publicado: (2021) -
Acta Nº677
por: Banco Central de Chile
Publicado: (2019) -
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Mitch Brinkkemper, et al.
Publicado: (2021) -
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
por: Chantal B F Vogels, et al.
Publicado: (2021) -
Case Report: Dacomitinib Overcomes Osimertinib Resistance in NSCLC Patient Harboring L718Q Mutation: A Case Report
por: Qian Shen, et al.
Publicado: (2021)